Fresenius SE & Co. KGaA / Key word(s): Change in Forecast 29.04.2015 22:13 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Fresenius raises 2015 earnings guidance Based on positive business prospects, Fresenius raises its earnings guidance for 2015. Fresenius now expects net income* growth of 13% to 16% in constant currency. Previously, the company expected net income* growth of 9% to 12% in constant currency. The company fully confirms its Group sales guidance. Sales are expected to increase by 7% to 10% in constant currency. In the United States, Fresenius Kabi exceeded our expectations in the first months of 2015. Due to significantly improved prospects in the U.S., Fresenius Kabi raises its outlook for 2015. For 2015, Fresenius Kabi now expects organic sales growth of 4% to 7%. EBIT growth in constant currency is expected to be in the range of 11% to 14%. Previously, Fresenius Kabi projected organic sales growth of 3% to 5% and an EBIT growth in constant currency in the range of 4% to 6%. * Net income attributable to shareholders of Fresenius SE & Co. KGaA; 2015 before integration costs (~EUR10 million before tax for hospitals acquired from Rhön-Klinikum AG), before costs for the efficiency program at Fresenius Kabi (~EUR100 million before tax), and before the disposal gain from the divestment of two HELIOS hospitals (EUR34 million before tax); 2014 before special items (Financial statements according to U.S. GAAP) Fresenius SE & Co. KGaA, represented by Fresenius Management SE, Board of Management Bad Homburg v.d.H., April 29, 2015 End of note 29.04.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Fresenius SE & Co. KGaA Else-Kröner-Straße 1 61352 Bad Homburg v.d.H. Germany Phone: +49 (0)6172 608-2485 Fax: +49 (0)6172 608-2488 E-mail: [email protected] Internet: www.fresenius.com ISIN: DE0005785604 WKN: 578560 Indices: DAX Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Hamburg, Hanover, Stuttgart; Terminbörse EUREX End of Announcement DGAP News-Service ---------------------------------------------------------------------------